PRA Health Sciences Inc (PRAH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:PRA Health Sciences Inc (PRAH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6589
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometrics, clinical pharmacology, strategic solutions, post-marketing research, clinical diagnostics, and safety and risk management. PRA spans its expertise in the therapeutic areas of biosimilars, oncology, hematology, respiratory, rare diseases, neurology, infectious diseases, cardio-metabolic and immunology. It caters to pharmaceutical and biotechnology industries. The company has presence in the US, Hong Kong, Russia, India, France, Italy, China, Japan, South Africa, Israel and Colombia among others. PRA is headquartered in Raleigh, North Carolina, the US.

PRA Health Sciences Inc (PRAH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PRA Health Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PRA Health Sciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
PRA Health Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PRA Health Sciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
PRA Health Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PRA Health Sciences Inc, Medical Equipment, Deal Details 10
Partnerships 10
Care Innovations Enters into Partnership with PRA Health Sciences 10
Equity Offering 11
PRA Health Sciences Prices Public Offering of Shares 11
PRA Health Sciences Raises USD416.3 Million in Public Offering of Shares 13
Acquisition 15
PRA Health Sciences Acquires Symphony Health Solutions 15
PRA Health Sciences Inc – Key Competitors 17
PRA Health Sciences Inc – Key Employees 18
PRA Health Sciences Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 21
Recent Developments 22
Strategy And Business Planning 22
May 04, 2017: PRA Health Sciences Announces The Center for Pediatric Clinical Development 22
Financial Announcements 23
Aug 01, 2018: PRA Health Sciences reports second quarter 2018 results and updates full year 2018 guidance 23
Apr 25, 2018: PRA Health Sciences Announces First Quarter 2018 Financial Results 25
Feb 21, 2018: PRA Health Sciences Reports Fourth Quarter 2017 Financial Results 27
Oct 25, 2017: PRA Health Sciences Reports Third Quarter 2017 Results and Updates Full Year 2017 Guidance 29
Aug 07, 2017: PRA Health Sciences Reports Second Quarter 2017 Results and Updates Full Year 2017 Guidance 31
Apr 25, 2017: PRA Health Sciences Reports First Quarter 2017 Results 33
Feb 22, 2017: PRA Health Sciences Reports Fourth Quarter and Full Year 2016 Results and Provides Q1 and Full Year 2017 Guidance 35
Corporate Communications 37
Apr 25, 2018: PRA Health Sciences Announces Senior Management Changes 37
Aug 14, 2017: PRA Health Sciences Announces Appointment of New Director 38
May 22, 2017: PRA Health Sciences Named International Clinical Research Company of the Year 39
May 02, 2017: PRA Health Sciences Named Clinical Research Company of the Year 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
PRA Health Sciences Inc, Medical Equipment, Key Facts, 2017 2
PRA Health Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
PRA Health Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PRA Health Sciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
PRA Health Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PRA Health Sciences Inc, Deals By Market, 2012 to YTD 2018 8
PRA Health Sciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Care Innovations Enters into Partnership with PRA Health Sciences 10
PRA Health Sciences Prices Public Offering of Shares 11
PRA Health Sciences Raises USD416.3 Million in Public Offering of Shares 13
PRA Health Sciences Acquires Symphony Health Solutions 15
PRA Health Sciences Inc, Key Competitors 17
PRA Health Sciences Inc, Key Employees 18
PRA Health Sciences Inc, Other Locations 19
PRA Health Sciences Inc, Subsidiaries 20
PRA Health Sciences Inc, Joint Venture 21

List of Figures
PRA Health Sciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
PRA Health Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
PRA Health Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
PRA Health Sciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
PRA Health Sciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PRA Health Sciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
PRA Health Sciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PRA Health Sciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[PRA Health Sciences Inc (PRAH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pact Group Holdings Ltd:企業の戦略・SWOT・財務情報
    Pact Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Pact Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mobile Telesystems:企業のM&A・事業提携・投資動向
    Mobile Telesystems - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mobile Telesystems Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Confused.com Limited:企業の戦略・SWOT・財務情報
    Confused.com Limited - Strategy, SWOT and Corporate Finance Report Summary Confused.com Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Heartland Payment Systems, Inc.:企業のM&A・事業提携・投資動向
    Heartland Payment Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Heartland Payment Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Taiwan Cooperative Bank, Ltd.:企業の戦略・SWOT・財務情報
    Taiwan Cooperative Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taiwan Cooperative Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ERG Renew SpA-エネルギー分野:企業M&A・提携分析
    Summary ERG Renew S.p.A. (ERG Renew), formerly Entad S.p.A., a subsidiary of ERG S.p.A, is a power company that generates electricity from renewable sources. The company generates electricity mainly through wind. ERG Renew and its subsidiaries operate in Italy, France, Bulgaria/Romania, Germany, and …
  • Fugro NV (FUR):電力:M&Aディール及び事業提携情報
    Summary Fugro NV (Fugro) is an integrated provider of geotechnical, survey, subsea and geosciences services. The company specializes in earth and engineering data services, from project preparation through to data acquisition, processing, analysis and interpretation, reporting and consulting. It ass …
  • Metro AG:企業の戦略・SWOT・財務情報
    Metro AG - Strategy, SWOT and Corporate Finance Report Summary Metro AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Antitope Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The company’s iTope technology is used to identify peptides; and T Cell Epitope Database is used for screening amino acid sequences from antibo …
  • Cisco Systems, Inc.:企業の戦略・SWOT・財務情報
    Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Constellation Pharmaceuticals Inc (CNST):企業の財務・戦略的SWOT分析
    Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Feintool International Holding AG (FTON):企業の財務・戦略的SWOT分析
    Feintool International Holding AG (FTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Targa Resources Partners LP (NGLS PR A)-石油・ガス分野:企業M&A・提携分析
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. The company provides midstream natural gas and natural gas liquids (NGL) services. Targa Resources carries out the gathering, compressing, treating, processing and selling of natural gas, and storing, fraction …
  • Crane Co (CR):企業の財務・戦略的SWOT分析
    Crane Co (CR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Franz Haniel & Cie. GmbH:企業の戦略・SWOT・財務分析
    Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report Summary Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Abbott Diagnostics:企業の製品パイプライン分析2018
    Summary Abbott Diagnostics, a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics portfolio. Its products include labo …
  • PIQUR Therapeutics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary PIQUR Therapeutics AG (PIQUR) is a developer of anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipeline products comprise PQR-309, PQR-620, PQR-530, PQR …
  • ALFA, S.A.B. de C.V.:企業の戦略・SWOT・財務分析
    ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Embera NeuroTherapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Embera NeuroTherapeutics Inc (Embera) is a contract research company that discovers and develops new treatments. The company’s product includes EMB-001, a drug combination for the stress response system and specific brain functions that results in craving and improvement associated with thes …
  • Horama SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Horama SA (Horama) is a biotechnology company, which develops gene therapy products based on recombinant adeno-associated virus (rAAV) vectors for the treatment of rare ophthalmic diseases, including retinopathies and maculopathies. Its pipeline gene replacement products include HORA-RPE65, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆